ArticleScientific reports2025

High-throughput transcriptomic screening reveals entrectinib as a repositioning opportunity in 19q12 autism spectrum disorder.

Drishti Guin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.